高等学校化学学报 ›› 2018, Vol. 39 ›› Issue (6): 1197.doi: 10.7503/cjcu20170740

• 有机化学 • 上一篇    下一篇

含哌嗪酰胺类杨梅素衍生物的合成及生物活性

阮祥辉, 赵洪菊, 张橙, 陈丽娟, 李普, 王一会, 贺鸣, 薛伟()   

  1. 绿色农药与农业生物工程国家重点实验室培育基地, 绿色农药与生物工程教育部重点实验室, 贵州大学精细化工研究开发中心, 贵阳 550025
  • 收稿日期:2017-11-16 出版日期:2018-06-10 发布日期:2018-05-18
  • 基金资助:
    国家重点研发计划项目(批准号: 2017YFD0200506)和贵州大学研究生创新基金(批准号: 2017059)资助.

Syntheses and Bioactivities of Myricetin Derivatives Containing Piperazine Acidamide Moiety

RUAN Xianghui, ZHAO Hongju, ZHANG Cheng, CHEN Lijuan, LI Pu, WANG Yihui, HE Ming, XUE Wei*()   

  1. State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Bioengineering of Ministry of Education, Center for Research and Development of Fine Chemicals, Guizhou University, Guiyang 550025, China
  • Received:2017-11-16 Online:2018-06-10 Published:2018-05-18
  • Contact: XUE Wei E-mail:wxue@gzu.edu.cn
  • Supported by:
    † Supported by the National Key Research and Development Program of China(No.2017YFD0200506) and the Innovation Fund for Graduate Student of Guizhou University, China(No.2017059).

摘要:

以杨梅苷、 哌嗪和各种芳香酸为原料, 通过甲基化保护羟基和脱苷形成选择性单一的杨梅素中间体, 然后以三步取代反应连接哌嗪和芳香酸, 合成了13个新型含哌嗪酰胺类杨梅素衍生物. 采用四甲基偶氮唑盐(MTT)比色法测试了化合物对人类乳腺癌细胞(MDA-MB-231)体外增殖的抑制活性. 结果表明, 大多数含哌嗪酰胺的杨梅素衍生物对MDA-MB-231细胞表现出较好的抑制活性. 当浓度为1 μmol/L时, 化合物4a和4i的抑制活性均高于阳性对照药盐酸表阿霉素; 当浓度为10 μmol/L时, 化合物4h和4i的抑制活性高达86.7%和83.6%.

关键词: 杨梅素, 哌嗪酰胺, 生物活性

Abstract:

Thirteen novel derivates of piperazine acidamide myricetin were synthesized with the raw materials of myricetin, piperazine and aromatic acids. First, the myricetin of high selectivity was obtained through methylation protection hydroxyl and deglucoside. Then, the intermediate underwent three-steps substitution reaction with the piperazine and various aromatic acids to form target compounds. Inhibitory activities of compounds on proliferation of human breast cancer cell line(MDA-MB-231) were tested by methyl thiazolyl tetrazolium(MTT) colorimetric assay in vitro. The experimental results demonstrated that most of the myricetin derivatives exhibited good inhibitory activity. Inhibitory activities of compounds 4a and 4i with the concentration of 1 μmol/L were higher than epirubicin hydrochloride as positive control drug, and the corresponding inhibitory activities were up to 86.7% and 83.6% at 10 μmol/L, respectively.

Key words: Myricetin, Piperazine amide, Bioactivity

中图分类号: 

TrendMD: